ABL Bio Inc. (KOSDAQ: 298380), a biotechnology company specializing in bispecific antibodies for immuno-oncology and neurodegenerative diseases, has announced a global licensing agreement with pharmaceutical
Author: Dylan Evans
Palmas Strengthens Public Healthcare with Investments in Infrastructure, Medications, and Staffing
In the first 100 days of the new administration, the Palmas City Hall has made healthcare one of its top priorities. Under the leadership of
Universe Pharmaceuticals Stock Plunges to 52-Week Low Amid Mounting Challenges
Universe Pharmaceuticals Inc. is facing increasing financial pressure as its stock has dropped to a new 52-week low of just $3.20. The sharp decline reflects